Kathleen M. Moreton
University of Bristol
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kathleen M. Moreton.
FEBS Letters | 1996
Csilla M. Eszes; Richard B. Sessions; Anthony R. Clarke; Kathleen M. Moreton; J. John Holbrook
High concentrations of ketoacid substrates inhibit most natural hydroxyacid dehydrogenases due to the formation of an abortive enzyme‐NAD+‐ketoacid complex. It was postulated that this substrate inhibition could be eliminated from lactate dehydrogenases if the rate of NAD+ dissociation could be increased. An analysis of the crystal structure of mammalian LDHs showed that the amide of the nicotinamide cofactor formed a water‐bridged hydrogen bond to S163. The LDH of Plasmodium falciparum is not inhibited by its substrate and, uniquely, in this enzyme the serine is replaced by a leucine. In the S163L mutant of human LDH‐M4 pyruvate inhibition is, indeed, abolished and the enzyme retains high activity. However, the major contribution to this effect comes from a weakening of the interaction of pyruvate with the enzyme‐coenzyme complex.
Proceedings of the National Academy of Sciences of the United States of America | 2011
Paul Curnow; Natalie D. Di Bartolo; Kathleen M. Moreton; Oluseye O. Ajoje; Nicholas P. Saggese; Paula J. Booth
Defining the structural features of a transition state is important in understanding a folding reaction. Here, we use Φ-value and double mutant analyses to probe the folding transition state of the membrane protein bacteriorhodopsin. We focus on the final C-terminal helix, helix G, of this seven transmembrane helical protein. Φ-values could be derived for 12 amino acid residues in helix G, most of which have low or intermediate values, suggesting that native structure is disrupted at these amino acid positions in the transition state. Notably, a cluster of residues between E204 and M209 all have Φ-values close to zero. Disruption of helix G is further confirmed by a low Φ-value of 0.2 between residues T170 on helix F and S226 on helix G, suggesting the absence of a native hydrogen bond between helices F and G. Φ-values for paired mutations involved in four interhelical hydrogen bonds revealed that all but one of these bonds is absent in the transition state. The unstructured helix G contrasts with Φ-values along helix B that are generally high, implying native structure in helix B in the transition state. Thus helix B seems to constitute part of a stable folding nucleus while the consolidation of helix G is a relatively late folding event. Polarization of secondary structure correlates with sequence position, with a structured helix B near the N terminus contrasting with an unstructured C-terminal helix G.
Trends in Biotechnology | 1994
Ayman S. El Hawrani; Kathleen M. Moreton; Richard B. Sessions; Anthony R. Clarke; J. John Holbrook
A prerequisite for the rational redesign of enzymes is that altering amino acids in an attempt to obtain new biological function does not unexpectedly alter the globular, natural framework of the native protein on which the design is being executed. The results of combinatorial-mutagenesis strategies suggest that random variation of amino acid sequence is most easily tolerated at the solvent-exposed surfaces of a protein. This review analyses effective redesigns of Bacillus stearothermophilus lactate dehydrogenase (bsLDH), in which all residue variations are at solvent-exposed surfaces. The majority of these variations were located within surface loops, which interconnect stable secondary structures traversing the globular core of the protein.
Biotechnology Letters | 2001
Dilek Turgut-Balik; Deborah K. Shoemark; Kathleen M. Moreton; Richard B. Sessions; J. John Holbrook
Over-production of lactate dehydrogenase (PfLDH) from Plasmodium falciparum from E. coli TG2 cells transformed with a pKK223-3 plasmid containing the wild type gene isolated by Bzik DJ, Fox BA, and Gonyer K (1993) Mol. Biochem. Parasit.59, 155–166, gave mostly an inactive protein after isolation. Sequencing the N-terminus of the over-produced protein showed that the major product commenced at an internal methionine. Truncation of the protein occurred due to the inappropriate priming from a Shine–Dalgarno (SD) sequence upstream of Met 35. Silent mutations of this SD sequence to remove the purine-rich region allowed over-production of the full length PfLDH up to 15 mg protein l−1 broth. The purified protein exhibited biochemical properties of an authentic LDH enzyme. However, high activity with 3-acetylpyridine adenine dinucleotide as well as with the natural cofactor, NAD, was also observed. The high-resolution X-ray structure obtained from the recombinant enzyme has provided the opportunity for the development of inhibitors specific to PfLDH.
Journal of Molecular Biology | 1989
A. Rawas; Kathleen M. Moreton; Hilary Muirhead; J. Williams
Crystals of duck ovotransferrin and duck apo-ovotransferrin have been grown from polyethylene glycol solutions. For both crystals, the space group is P2(1)2(1)2(1), the unit cell dimensions for the ovotransferrin are a = 49.6 A, b = 85.6 A, c = 178.7 A and for the apo-ovotransferrin a = 77.6 A, b = 98.8 A, c = 127.0 A, giving four molecules in the unit cell.
Biotechnology Letters | 2001
Dilek Turgut-Balik; Deborah K. Shoemark; Richard B. Sessions; Kathleen M. Moreton; J. John Holbrook
Several site-directed mutations of residues around the active site of the lactate dehydrogenase from Plasmodium falciparum are described. These include changes to three highly, but not completely, conserved residues in the pocket of the active site and also three changes (including deletions) to the active site loop. Changes to residues in the active-site pocket resulted in little or no over-production of protein and no enzymic activity. Likewise, a five residue deletion from the active site loop gave no over-produced protein, while a two residue deletion and changes of residue type in this loop were tolerated. The results are discussed in the light of this protein being a suitable target for novel anti-malarials.
Biochemistry | 1992
Helen M. Wilks; Kathleen M. Moreton; David J. Halsall; Keith W. Hart; Richard D. Sessions; Anthony R. Clarke; J. John Holbrook
Journal of Molecular Biology | 1996
As El Hawrani; Richard B. Sessions; Kathleen M. Moreton; J. John Holbrook
Protein Engineering | 1999
Co Hewitt; Cm Eszes; Richard B. Sessions; Kathleen M. Moreton; Tr Dafforn; Jiro Takei; Christopher E. Dempsey; Ar Clarke; J. John Holbrook
Journal of Molecular Biology | 2006
Emma L. R. Compton; Nicola A. Farmer; Mark Lorch; Jody M. Mason; Kathleen M. Moreton; Paula J. Booth